|
x € million
|
Notes
|
Continuing operations
|
Discontinued operations
|
Total
|
||
|
Before
exceptional items |
Exceptional
items (note 9) |
Total
|
||||
|
Net sales
|
|
8,757
|
-
|
8,757
|
-
|
8,757
|
|
Other operating income
|
4
|
164
|
-
|
164
|
-
|
164
|
|
|
|
8,921
|
-
|
8,921
|
-
|
8,921
|
|
Own work capitalized
|
|
52
|
-
|
52
|
-
|
52
|
|
Change in inventories of intermediates and finished goods
|
|
73
|
-
|
73
|
-
|
73
|
|
Raw materials and consumables used
|
|
(4,793)
|
-
|
(4,793)
|
-
|
(4,793)
|
|
Work subcontracted and other external costs
|
|
(1,522)
|
-
|
(1,522)
|
-
|
(1,522)
|
|
Employee benefits costs
|
5
|
(1,389)
|
-
|
(1,389)
|
-
|
(1,389)
|
|
Depreciation and amortization
|
6
|
(424)
|
(150)
|
(574)
|
-
|
(574)
|
|
Other operating costs
|
7
|
(95)
|
(26)
|
(121)
|
-
|
(121)
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
823
|
(176)
|
647
|
-
|
647
|
|
Interest costs
|
8
|
(85)
|
-
|
(85)
|
-
|
(85)
|
|
Other financial income and expense
|
8
|
10
|
-
|
10
|
-
|
10
|
|
Share of the profit of associates
|
|
(2)
|
-
|
(2)
|
-
|
(2)
|
|
|
|
|
|
|
|
|
|
Profit before income tax expense
|
|
746
|
(176)
|
570
|
-
|
570
|
|
Income tax expense
|
10
|
(183)
|
47
|
(136)
|
-
|
(136)
|
|
|
|
|
|
|
|
|
|
Profit for the year
|
|
563
|
(129)
|
434
|
-
|
434
|
|
|
|
|
|
|
|
|
|
Of which:
|
|
|
|
|
|
|
|
- Profit attributable to minority interests
|
|
5
|
-
|
5
|
-
|
5
|
|
- Net profit attributable to equity
holders of Royal DSM N.V. |
|
558
|
(129)
|
429
|
-
|
429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit attributable to equity holders
of Royal DSM N.V. |
|
558
|
(129)
|
429
|
-
|
429
|
|
Dividend on cumulative preference shares
|
|
(10)
|
-
|
(10)
|
-
|
(10)
|
|
|
|
|
|
|
|
|
|
Net profit available for holders of ordinary shares
|
|
548
|
(129)
|
419
|
-
|
419
|
|
|
|
|
|
|
|
|
|
Average number of ordinary shares outstanding (x 1000)
|
|
|
|
|
|
178,541
|
|
Effect of dilution due to share options (x 1000)
|
|
|
|
|
|
1,475
|
|
|
|
|
|
|
|
|
|
Adjusted weighted average number of ordinary shares
(x 1000) |
|
|
|
|
|
180,016
|
|
|
|
|
|
|
|
|
|
Per ordinary share in euro:
|
|
|
|
|
|
|
|
- Basic earnings
|
|
3.07
|
(0.72)
|
2.35
|
-
|
2.35
|
|
- Diluted earnings
|
|
3.05
|
(0.72)
|
2.33
|
-
|
2.33
|
|
- Dividend paid in the period
|
|
|
|
|
|
1.00
|
|
- Dividend for the year
|
|
|
|
|
|
1.20
|
|
x € million
|
Notes
|
Continuing operations
|
Discontinued
operations |
Total
|
||
|
Before
exceptional items |
Exceptional
items (note 9) |
Total
|
||||
|
Net sales
|
|
8,352
|
-
|
8,352
|
28
|
8,380
|
|
Other operating income
|
4
|
210
|
73
|
283
|
2
|
285
|
|
|
|
8,562
|
73
|
8,635
|
30
|
8,665
|
|
Own work capitalized
|
|
39
|
-
|
39
|
-
|
39
|
|
Change in inventories of intermediates and finished goods
|
|
63
|
-
|
63
|
(5)
|
58
|
|
Raw materials and consumables used
|
|
(4,536)
|
-
|
(4,536)
|
(18)
|
(4,554)
|
|
Work subcontracted and other external costs
|
|
(1,481)
|
-
|
(1,481)
|
(4)
|
(1,485)
|
|
Employee benefits costs
|
5
|
(1,338)
|
9
|
(1,329)
|
(3)
|
(1,332)
|
|
Depreciation and amortization
|
6
|
(440)
|
(11)
|
(451)
|
-
|
(451)
|
|
Other operating costs
|
7
|
(34)
|
(97)
|
(131)
|
(1)
|
(132)
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
835
|
(26)
|
809
|
(1)
|
808
|
|
Interest costs
|
8
|
(84)
|
-
|
(84)
|
-
|
(84)
|
|
Other financial income and expense
|
8
|
3
|
-
|
3
|
-
|
3
|
|
Share of the profit of associates
|
|
1
|
4
|
5
|
-
|
5
|
|
|
|
|
|
|
|
|
|
Profit before income tax expense
|
|
755
|
(22)
|
733
|
(1)
|
732
|
|
Income tax expense
|
10
|
(199)
|
18
|
(181)
|
1
|
(180)
|
|
|
|
|
|
|
|
|
|
Profit for the year
|
|
556
|
(4)
|
552
|
0
|
552
|
|
|
|
|
|
|
|
|
|
Of which:
|
|
|
|
|
|
|
|
- Profit attributable to minority interests
|
|
5
|
-
|
5
|
-
|
5
|
|
- Net profit attributable to equity
holders of Royal DSM N.V. |
|
551
|
(4)
|
547
|
0
|
547
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit attributable to equity holders
of Royal DSM N.V. |
|
551
|
(4)
|
547
|
0
|
547
|
|
Dividend on cumulative preference shares
|
|
(10)
|
-
|
(10)
|
-
|
(10)
|
|
|
|
|
|
|
|
|
|
Net profit available for holders of ordinary shares
|
|
541
|
(4)
|
537
|
0
|
537
|
|
|
|
|
|
|
|
|
|
Average number of ordinary shares
outstanding (x 1000) |
|
|
|
|
|
189,550
|
|
Effect of dilution due to share options (x 1000)
|
|
|
|
|
|
1,200
|
|
|
|
|
|
|
|
|
|
Adjusted weighted average number of ordinary shares
(x 1000) |
|
|
|
|
|
190,750
|
|
|
|
|
|
|
|
|
|
Per ordinary share in euro:
|
|
|
|
|
|
|
|
- Basic earnings
|
|
2.85
|
(0.02)
|
2.83
|
-
|
2.83
|
|
- Diluted earnings
|
|
2.84
|
(0.02)
|
2.82
|
-
|
2.82
|
|
- Dividend paid in the period
|
|
|
|
|
|
1.04
|
|
- Dividend for the year
|
|
|
|
|
|
1.00
|
|
x € million
|
Notes
|
2007
|
2006
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Non-current assets
|
|
|
|
|
Intangible assets
|
11
|
1,037
|
1,008
|
|
Property, plant and equipment
|
12
|
3,440
|
3,655
|
|
Deferred tax assets
|
10
|
346
|
496
|
|
Prepaid pension costs
|
24
|
1,169
|
918
|
|
Associates
|
13
|
20
|
26
|
|
Other financial assets
|
14
|
126
|
100
|
|
|
|
6,138
|
6,203
|
|
Current assets
|
|
|
|
|
Inventories
|
15
|
1,547
|
1,515
|
|
Trade receivables
|
16
|
1,452
|
1,377
|
|
Other receivables
|
16
|
235
|
362
|
|
Financial derivatives
|
23
|
83
|
79
|
|
Current investments
|
|
4
|
3
|
|
Cash and cash equivalents
|
|
369
|
552
|
|
|
|
3,690
|
3,888
|
|
Assets held for sale
|
|
-
|
-
|
|
|
|
3,690
|
3,888
|
|
|
|
|
|
|
Total
|
|
9,828
|
10,091
|
|
|
|||
|
Equity and liabilities
|
|
|
|
|
|
|
|
|
|
Equity
|
17
|
|
|
|
Royal DSM N.V. Shareholders' equity
|
|
5,310
|
5,784
|
|
Minority interests
|
|
73
|
71
|
|
|
|
5,383
|
5,855
|
|
Non-current liabilities
|
|
|
|
|
Deferred tax liabilities
|
10
|
344
|
383
|
|
Employee-benefits liabilities
|
24
|
273
|
304
|
|
Provisions
|
18
|
170
|
188
|
|
Borrowings
|
19
|
1,560
|
907
|
|
Other non-current liabilities
|
20
|
35
|
44
|
|
|
|
2,382
|
1,826
|
|
Current liabilities
|
|
|
|
|
Employee-benefits liabilities
|
24
|
9
|
21
|
|
Provisions
|
18
|
91
|
127
|
|
Borrowings
|
19
|
192
|
607
|
|
Financial derivatives
|
23
| ||